According to the official website of Beijing Tsinghua Changgung Hospital, affiliated with Tsinghua University, on the 4th (today), Professor Wang Yaxing has been elected as a Fellow of the Academia Ophthalmologica Internationalis (AOI) at the AOI’s 50th Anniversary Congress held recently in Leiden, the Netherlands.
Public information shows that Wang Yaxing is currently a tenured associate professor, researcher, and doctoral supervisor at Tsinghua University School of Medicine. She also serves as a researcher and associate chief physician at the Ophthalmology Center of Beijing Tsinghua Changgung Hospital, and is the Executive Director of the Beijing Eye Research Institute (BERI).
Wang began her medical education in 1995, enrolling in the Clinical Medicine program at Shanxi Medical University. She later earned a master’s degree in ophthalmology at Capital Medical University, followed by a Ph.D. in ophthalmology from Capital Medical University and Heidelberg University (Germany) through a joint program.
She has received systematic clinical and research training in glaucoma at Moorfields Eye Hospital and University College London in the UK, and conducted research at the Devers Eye Institute in the United States—both internationally renowned institutions in ophthalmology.
Professionally, Wang Yaxing worked for many years at Beijing Tongren Hospital, where she held positions ranging from ophthalmologist to attending physician, associate chief physician, researcher, and associate professor between 2006 and 2022.
In October 2024, she officially joined Tsinghua University in her current role, continuing her research in ophthalmology.
Over the years, Wang has been committed to advancing the integration of basic and translational research in ophthalmology. Her research focuses on the early diagnosis of glaucoma and high myopia-related complications, ophthalmic epidemiology, medical imaging and engineering integration, and ophthalmic imaging analytics. She has made a number of internationally impactful contributions in these areas.
For example, just last month, her study titled “Trends and Projections of Myopia and High Myopia Among Chinese Children and Adolescents by 2050: A Nationwide Data-Based Study” was published in The Lancet Regional Health – Western Pacific, a leading international medical journal.
This study is the largest, longest-running, and most comprehensive epidemiological research on myopia among Chinese youth to date. It tracked prevalence over a 25-year period and used scientific data to forecast future trends. Wang co-authored the study with Dean Huang Tianyin of Tsinghua University School of Medicine.
Back in 2021, Wang and her team were the first in the world to report and analyze the incidence of glaucoma in people with high myopia, offering valuable insights for glaucoma prevention and treatment strategies.
To date, Wang has published over 300 SCI-indexed papers, with more than 100 as first or corresponding author, in leading medical and ophthalmology journals. Her publications have been cited over 50,000 times, with an H-index of 93, placing her among the world’s most influential ophthalmic researchers.
She has also participated in many major international research initiatives; received funding from the Beijing Outstanding Talent Program, Beijing Health Commission pilot projects, and the National Natural Science Foundation of China; and has been awarded national honors such as the National Science and Technology Progress Award. Additionally, she has contributed to the formulation of key clinical guidelines, including those of the World Glaucoma Association, the latest European Glaucoma Society guidelines, and the Chinese Glaucoma Guidelines. She currently serves as Associate Editor of the European Journal of Ophthalmology.
Due to her outstanding contributions to ophthalmic research, Wang Yaxing was named to the “Top 100 in Asia-Pacific Ophthalmology” list at the 40th Asia-Pacific Academy of Ophthalmology (APAO 2025) Congress held in New Delhi, India in April this year.
Her election as a Fellow of the Academia Ophthalmologica Internationalis is considered one of the highest honors in global ophthalmology.

Pic.1 Congress scene
The Academia Ophthalmologica Internationalis (AOI) is one of the world’s most prestigious academic organizations in ophthalmology. Fellowship in AOI is a lifetime honor, limited to 100 members worldwide. As of now, there are 97 Fellows from 33 countries, including 8 scholars from China.
According to Tsinghua University School of Medicine, Wang Yaxing is currently the youngest active AOI Fellow. In fact, Tsinghua University and its affiliated Beijing Tsinghua Changgung Hospital now have two AOI Fellows — Professor Huang Tianyin and Associate Professor Wang Yaxing — ranking first among all universities and medical institutions in China.